ArticleHealthcare (Basel, Switzerland)2022
Intelligent Deep-Learning-Enabled Decision-Making Medical System for Pancreatic Tumor Classification on CT Images.
Article in Healthcare (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
11 citing papers in PubMed.
- Artificial intelligence in pancreatic cancer: applications in early detection, tumor staging, and survival prediction-a comprehensive review.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026Review
- Detection and Classification of Pancreatic Cancer Nodules on CT Images using U-Net and Ensemble Models.Current medical imaging · 2026Article
- DeepOptimalNet: optimized deep learning model for early diagnosis of pancreatic tumor classification in CT imaging.Abdominal radiology (New York) · 2025Article
- Advancements in Radiomics-Based AI for Pancreatic Ductal Adenocarcinoma.Bioengineering (Basel, Switzerland) · 2025Review
- Enhancing pancreatic cancer detection in CT images through secretary wolf bird optimization and deep learning.Scientific reports · 2025Article
- Automated CAD system for early detection and classification of pancreatic cancer using deep learning model.PloS one · 2025Article
- Explainable artificial intelligence in pancreatic cancer prediction: from transparency to clinical decision-making.Frontiers in oncology · 2025Review
- Artificial Intelligence in Pancreatic Image Analysis: A Review.Sensors (Basel, Switzerland) · 2024Review
- CT scan pancreatic cancer segmentation and classification using deep learning and the tunicate swarm algorithm.PloS one · 2023Article
- Computational Intelligence-Based Melanoma Detection and Classification Using Dermoscopic Images.Computational intelligence and neuroscience · 2022Article
- Deep Learning Approaches for Automatic Localization in Medical Images.Computational intelligence and neuroscience · 2022Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Decision-making medical systems (DMS) refer to the design of decision techniques in the healthcare sector. They involve a procedure of employing ideas and decisions related to certain processes such as data acquisition, processing, judgment, and conclusion. Pancreatic cancer is a lethal type of cancer, and its prediction is ineffective with current techniques. Automated detection and classification of pancreatic tumors can be provided by the computer-aided diagnosis (CAD) model using radiological images such as computed tomography (CT) and magnetic resonance imaging (MRI). The recently developed machine learning (ML) and deep learning (DL) models can be utilized for the automated and timely detection of pancreatic cancer. In light of this, this article introduces an intelligent deep-learning-enabled decision-making medical system for pancreatic tumor classification (IDLDMS-PTC) using CT images. The major intention of the IDLDMS-PTC technique is to examine the CT images for the existence of pancreatic tumors. The IDLDMS-PTC model derives an emperor penguin optimizer (EPO) with multilevel thresholding (EPO-MLT) technique for pancreatic tumor segmentation. Additionally, the MobileNet model is applied as a feature extractor with optimal auto encoder (AE) for pancreatic tumor classification. In order to optimally adjust the weight and bias values of the AE technique, the multileader optimization (MLO) technique is utilized. The design of the EPO algorithm for optimal threshold selection and the MLO algorithm for parameter tuning shows the novelty. A wide range of simulations was executed on benchmark datasets, and the outcomes reported the promising performance of the IDLDMS-PTC model on the existing methods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.